AI-Enhanced Fertility Treatments

The cruise ship’s fertility program integrates precision bioengineering and artificial intelligence to improve reproductive outcomes. Utilizing AI algorithms, this program identifies high-quality oocytes (eggs) with greater diagnostic accuracy, improving the success rates of fertility treatments. This non-invasive approach is particularly beneficial for couples seeking natural, personalized fertility solutions.

MSCs therapy sourced from various tissues including bone marrow and adipose tissue can improve age-related ovarian function decline and the success rate of in vitro maturation (IVM) in assisted reproductive therapy. Treatment involves stem cell injections over 2 consecutive days, with results seen within 8 weeks and the affects further intensified by 6 months.